Home » Topics » BioWorld Science

BioWorld Science
RSS

Positive topline data from phase I trial of prophylactic CMV vaccine candidate VBI-1501

May 11, 2018

Lundbeck identifies novel phosphodiesterase PDE1 inhibitors

May 11, 2018

Nimbus Lakshmi patents novel TYK2 inhibitors

May 11, 2018

Novel liver X receptor beta agonists divulged by Merck & Co.

May 11, 2018

ROCK and PKC inhibitor AR-13503 in development for ocular disorders

May 11, 2018

Mainline Biosciences submits pre-IND meeting information package for MLB-1707

May 11, 2018

Promising in vivo results for EP-055, a potential nonhormonal male contraceptive

May 11, 2018

First patient dosed in the phase I/II trial of KB-103

May 11, 2018

EVOLVE-MS-1 trial shows ALKS-8700 effects in patients with relapsing remitting multiple sclerosis

May 11, 2018

SPRINT-MS trial: phase II results of ibudilast treatment in progressive multiple sclerosis

May 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...